{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,6]],"date-time":"2026-09-06T15:09:54Z","timestamp":1788707394597,"version":"build-2803163510"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,9,6]]},"DOI":"10.7759\/cureus.115857","type":"journal-article","created":{"date-parts":[[2026,9,6]],"date-time":"2026-09-06T14:48:44Z","timestamp":1788706124000},"source":"Crossref","is-referenced-by-count":0,"title":["Association Between Blood Transfusion Volume and Adverse Clinical Outcomes in Chronic Liver Disease: A Retrospective Observational Study"],"prefix":"10.7759","author":[{"given":"Aditya","family":"Saha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akshay","family":"Saha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neelam","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.1040752","article-title":"Liver enzyme alteration: a guide for clinicians","volume":"172","author":"Giannini EG","year":"2005","unstructured":"Giannini EG, Testa R, Savarino V. Liver enzyme alteration: a guide for clinicians. CMAJ. 2005, 172:367-79. 10.1503\/cmaj.1040752","journal-title":"CMAJ"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2005.10.013","article-title":"Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies","volume":"44","author":"D'Amico G","year":"2006","unstructured":"D'Amico G, Garcia-Tsao G, Pagliaro L. Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies. J Hepatol. 2006, 44:217-31. 10.1016\/j.jhep.2005.10.013","journal-title":"J Hepatol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1211801","article-title":"Transfusion strategies for acute upper gastrointestinal bleeding","volume":"368","author":"Villanueva C","year":"2013","unstructured":"Villanueva C, Colomo A, Bosch A, et al.. Transfusion strategies for acute upper gastrointestinal bleeding. N Engl J Med. 2013, 368:11-21. 10.1056\/NEJMoa1211801","journal-title":"N Engl J Med"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.0040296","article-title":"The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"4","author":"von Elm E","year":"2007","unstructured":"von Elm E, Altman DG, Egger M, Pocock SJ, G\u00f8tzsche PC, Vandenbroucke JP. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. PLoS Med. 2007, 4:e296. 10.1371\/journal.pmed.0040296","journal-title":"PLoS Med"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2015.05.022","article-title":"Expanding consensus in portal hypertension: report of the Baveno VI Consensus Workshop: stratifying risk and individualizing care for portal hypertension","volume":"63","author":"de Franchis R","year":"2015","unstructured":"de Franchis R. Expanding consensus in portal hypertension: report of the Baveno VI Consensus Workshop: stratifying risk and individualizing care for portal hypertension. J Hepatol. 2015, 63:743-52. 10.1016\/j.jhep.2015.05.022","journal-title":"J Hepatol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-018-1018-z","article-title":"Hepatic encephalopathy: definition, clinical grading and diagnostic principles","volume":"79","author":"Weissenborn K","year":"2019","unstructured":"Weissenborn K. Hepatic encephalopathy: definition, clinical grading and diagnostic principles. Drugs. 2019, 79:5-9. 10.1007\/s40265-018-1018-z","journal-title":"Drugs"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1053\/jhep.2001.22172","article-title":"A model to predict survival in patients with end-stage liver disease","volume":"33","author":"Kamath PS","year":"2001","unstructured":"Kamath PS, Wiesner RH, Malinchoc M, et al.. A model to predict survival in patients with end-stage liver disease. Hepatology. 2001, 33:464-70. 10.1053\/jhep.2001.22172","journal-title":"Hepatology"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1002\/hep.28906","article-title":"Portal hypertensive bleeding in cirrhosis: risk stratification, diagnosis, and management 2016 practice guidance by the American Association for the Study of Liver Diseases","volume":"65","author":"Garcia-Tsao G","year":"2017","unstructured":"Garcia-Tsao G, Abraldes JG, Berzigotti A, Bosch J. Portal hypertensive bleeding in cirrhosis: risk stratification, diagnosis, and management 2016 practice guidance by the American Association for the Study of Liver Diseases. Hepatology. 2017, 65:310-35. 10.1002\/hep.28906","journal-title":"Hepatology"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2022.03.024","article-title":"Corrigendum to 'Baveno VII - renewing consensus in portal hypertension' [J Hepatol (2022) 959-974]","volume":"77","author":"de Franchis R","year":"2022","unstructured":"de Franchis R, Bosch J, Garcia-Tsao G, Reiberger T, Ripoll C. Corrigendum to 'Baveno VII - renewing consensus in portal hypertension' [J Hepatol (2022) 959-974]. J Hepatol. 2022, 77:271. 10.1016\/j.jhep.2022.03.024","journal-title":"J Hepatol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1038\/nrgastro.2009.149","article-title":"The clinical use of HVPG measurements in chronic liver disease","volume":"6","author":"Bosch J","year":"2009","unstructured":"Bosch J, Abraldes JG, Berzigotti A, Garc\u00eda-Pagan JC. The clinical use of HVPG measurements in chronic liver disease. Nat Rev Gastroenterol Hepatol. 2009, 6:573-82. 10.1038\/nrgastro.2009.149","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2015-309262","article-title":"UK guidelines on the management of variceal haemorrhage in cirrhotic patients","volume":"64","author":"Tripathi D","year":"2015","unstructured":"Tripathi D, Stanley AJ, Hayes PC, et al.. UK guidelines on the management of variceal haemorrhage in cirrhotic patients. Gut. 2015, 64:1680-704. 10.1136\/gutjnl-2015-309262","journal-title":"Gut"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2021.09.003","article-title":"EASL Clinical Practice Guidelines on prevention and management of bleeding and thrombosis in patients with cirrhosis","volume":"76","year":"2022","unstructured":"EASL Clinical Practice Guidelines on prevention and management of bleeding and thrombosis in patients with cirrhosis. J Hepatol. 2022, 76.1151-84. 10.1016\/j.jhep.2021.09.003","journal-title":"J Hepatol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1002\/hep.21907","article-title":"Prevention and management of gastroesophageal varices and variceal hemorrhage in cirrhosis","volume":"46","author":"Garcia-Tsao G","year":"2007","unstructured":"Garcia-Tsao G, Sanyal AJ, Grace ND, Carey W. Prevention and management of gastroesophageal varices and variceal hemorrhage in cirrhosis. Hepatology. 2007, 46:922-38. 10.1002\/hep.21907","journal-title":"Hepatology"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1055\/a-1939-4887","article-title":"Endoscopic diagnosis and management of esophagogastric variceal hemorrhage: European Society of Gastrointestinal Endoscopy (ESGE) guideline","volume":"54","author":"Gralnek IM","year":"2022","unstructured":"Gralnek IM, Camus Duboc M, Garcia-Pagan JC, et al.. Endoscopic diagnosis and management of esophagogastric variceal hemorrhage: European Society of Gastrointestinal Endoscopy (ESGE) guideline. Endoscopy. 2022, 54:1094-120. 10.1055\/a-1939-4887","journal-title":"Endoscopy"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(14)61999-1","article-title":"Restrictive versus liberal blood transfusion for acute upper gastrointestinal bleeding (TRIGGER): a pragmatic, open-label, cluster randomised feasibility trial","volume":"386","author":"Jairath V","year":"2015","unstructured":"Jairath V, Kahan BC, Gray A, et al.. Restrictive versus liberal blood transfusion for acute upper gastrointestinal bleeding (TRIGGER): a pragmatic, open-label, cluster randomised feasibility trial. Lancet. 2015, 386:137-44. 10.1016\/S0140-6736(14)61999-1","journal-title":"Lancet"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1213\/ANE.0000000000005873","article-title":"A global definition of patient blood management","volume":"135","author":"Shander A","year":"2022","unstructured":"Shander A, Hardy JF, Ozawa S, et al.. A global definition of patient blood management. Anesth Analg. 2022, 135:476-88. 10.1213\/ANE.0000000000005873","journal-title":"Anesth Analg"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2016.9185","article-title":"Clinical practice guidelines from the AABB: red blood cell transfusion thresholds and storage","volume":"316","author":"Carson JL","year":"2016","unstructured":"Carson JL, Guyatt G, Heddle NM, et al.. Clinical practice guidelines from the AABB: red blood cell transfusion thresholds and storage. JAMA. 2016, 316:2025-35. 10.1001\/jama.2016.9185","journal-title":"JAMA"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.i1351","article-title":"Effect of restrictive versus liberal transfusion strategies on outcomes in patients with cardiovascular disease in a non-cardiac surgery setting: systematic review and meta-analysis","volume":"352","author":"Docherty AB","year":"2016","unstructured":"Docherty AB, O'Donnell R, Brunskill S, et al.. Effect of restrictive versus liberal transfusion strategies on outcomes in patients with cardiovascular disease in a non-cardiac surgery setting: systematic review and meta-analysis. BMJ. 2016, 352:i1351. 10.1136\/bmj.i1351","journal-title":"BMJ"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.21037\/amj.2018.12.05","article-title":"Blood transfusion strategy in cirrhotic patients with active upper GI bleeding","volume":"4","author":"Nelamangala-Ramakrishnaiah VP","year":"2019","unstructured":"Nelamangala-Ramakrishnaiah VP, Chellappa V, Goneppanavar M. Blood transfusion strategy in cirrhotic patients with active upper GI bleeding. AME Med J. 2019, 4:1. 10.21037\/amj.2018.12.05","journal-title":"AME Med J"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1002\/hep.27210","article-title":"Hepatic encephalopathy in chronic liver disease: 2014 practice guideline by the American Association for the Study of Liver Diseases and the European Association for the Study of the Liver","volume":"60","author":"Vilstrup H","year":"2014","unstructured":"Vilstrup H, Amodio P, Bajaj J, et al.. Hepatic encephalopathy in chronic liver disease: 2014 practice guideline by the American Association for the Study of Liver Diseases and the European Association for the Study of the Liver. Hepatology. 2014, 60:715-35. 10.1002\/hep.27210","journal-title":"Hepatology"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2009.04211.x","article-title":"Review article: the modern management of hepatic encephalopathy","volume":"31","author":"Bajaj JS","year":"2010","unstructured":"Bajaj JS. Review article: the modern management of hepatic encephalopathy. Aliment Pharmacol Ther. 2010, 31:537-47. 10.1111\/j.1365-2036.2009.04211.x","journal-title":"Aliment Pharmacol Ther"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/501813-association-between-blood-transfusion-volume-and-adverse-clinical-outcomes-in-chronic-liver-disease-a-retrospective-observational-study","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,6]],"date-time":"2026-09-06T14:48:45Z","timestamp":1788706125000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/501813-association-between-blood-transfusion-volume-and-adverse-clinical-outcomes-in-chronic-liver-disease-a-retrospective-observational-study"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,6]]},"references-count":21,"URL":"https:\/\/doi.org\/10.7759\/cureus.115857","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9,6]]}}}